Tables and figures

Table 1: Characteristics of study populations, with proportions admitted/discharged and re-presentation rates for ED discharges (with univariable regression analysis).
Table 2: Intranasal management strategies for ED patients.
Table 3: Outcomes following re-presentation by intranasal management
Figure 1: Combination graphic to communicate trends in data over 12-week audit period: 1) The bar chart forming the background shows sequential opening of centres across the UK as the audit period progressed, 2) The box and whisker plots show the median, range and interquartile range of epistaxis patients presenting per centre per week for each of the three 4-week audit periods, 3) The scatter plot and error bars are COVID-19 swab rates (%) (diamonds) and positive swab rates (%) (crosses) with 95% confidence intervals, 4) The grey line chart is the 7-day rolling average of UK cases from 1st March to 31st July (available at:https://coronavirus.data.gov.uk/cases).
Figure 2: Sankey chart visualising proportions of patients being admitted or discharged from the ED, with rates of subsequent re-presentation, stratified by definitive intranasal management.